about
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myelomaPromises and challenges of MicroRNA-based treatment of multiple myelomaTransferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma.Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.Emerging pathways as individualized therapeutic target of multiple myeloma.TRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnology.Mir-34: a new weapon against cancer?Gene interference strategies as a new tool for the treatment of prostate cancer.Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer.Vector-independent transmembrane transport of oligodeoxyribonucleotides involves p38 mitogen activated protein kinase phosphorylation.
P2860
Q35108549-4D900292-406B-4763-97DC-017F57334157Q36419086-249F907F-990D-4C33-B88C-63FF6FFDD7FCQ37618873-FF068A36-4AB8-40FD-9BCE-D17BA387EB96Q37910273-C0481127-3162-403E-997E-A31C1B80BF13Q38112176-ACA6656E-AAF7-4FBA-AD0B-ADB27C430CA6Q38137746-EA113B36-901B-4379-AC0F-9F1C747FE843Q38253374-E60F0F22-967C-4BCD-91C2-E03C6B3F95F0Q38518046-A1742D8C-EADE-4718-AFF9-E4C3BBEB1DD8Q39196485-349D75A3-6E7F-48FB-BE4F-8A26C1FEEEB1Q42659834-BCD52BAB-EF69-4BFA-B606-2B26737B1AFC
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Oligonucleotide delivery in cancer therapy.
@en
Oligonucleotide delivery in cancer therapy.
@nl
type
label
Oligonucleotide delivery in cancer therapy.
@en
Oligonucleotide delivery in cancer therapy.
@nl
prefLabel
Oligonucleotide delivery in cancer therapy.
@en
Oligonucleotide delivery in cancer therapy.
@nl
P2860
P1476
Oligonucleotide delivery in cancer therapy.
@en
P2093
Daniela De Stefano
Giuseppe De Rosa
P2860
P304
P356
10.1517/17425247.2010.527942
P407
P50
P577
2010-11-01T00:00:00Z